K3 Capital Group (LON:K3C) Receives Corporate Rating from FinnCap

Share on StockTwits

K3 Capital Group (LON:K3C)‘s stock had its “corporate” rating reaffirmed by investment analysts at FinnCap in a report released on Tuesday, ThisIsMoney.Co.Uk reports.

LON:K3C opened at GBX 153 ($1.88) on Tuesday. The company has a market capitalization of $64.58 million and a P/E ratio of 15.61. The company has a current ratio of 2.15, a quick ratio of 2.06 and a debt-to-equity ratio of 11.90. K3 Capital Group has a 12 month low of GBX 116.08 ($1.43) and a 12 month high of GBX 295.90 ($3.64). The firm has a fifty day simple moving average of GBX 168.03 and a 200-day simple moving average of GBX 196.63.

K3 Capital Group Company Profile

K3 Capital Group PLC provides advisory services in the United Kingdom. It offers sell side advisory services to SME businesses in engineering, manufacturing, construction, technology, retail, wholesale, distribution, and business service sectors; company sales lead advisory and transaction support, and handling services; and business transfer services to clients in retail, catering, care, commercial, licensed and leisure markets.

Featured Story: What Is An Exchange-Traded Fund (ETF)?

Receive News & Ratings for K3 Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K3 Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Anticipate US Ecology Inc  Will Post Quarterly Sales of $229.50 Million
Brokerages Anticipate US Ecology Inc Will Post Quarterly Sales of $229.50 Million
Zacks: Analysts Expect ICF International Inc  Will Announce Quarterly Sales of $346.56 Million
Zacks: Analysts Expect ICF International Inc Will Announce Quarterly Sales of $346.56 Million
Kadant Inc.  Expected to Announce Quarterly Sales of $148.99 Million
Kadant Inc. Expected to Announce Quarterly Sales of $148.99 Million
Cisco Systems  Stock Rating Upgraded by Morgan Stanley
Cisco Systems Stock Rating Upgraded by Morgan Stanley
Zacks Investment Research Downgrades NCS Multistage  to Hold
Zacks Investment Research Downgrades NCS Multistage to Hold
GlaxoSmithKline  PT Set at GBX 1,700 by JPMorgan Chase & Co.
GlaxoSmithKline PT Set at GBX 1,700 by JPMorgan Chase & Co.


© 2006-2020 Ticker Report